跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
吳 佳璋
教授
,
泌尿學科
主治醫師
,
衛生福利部雙和醫院
成員
,
臺北醫學大學泌尿腎臟研究中心
https://orcid.org/0000-0001-7476-0772
電子郵件
charleswjj
yahoo.com
tw
h-index
953
引文
18
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2005
2023
每年研究成果
概覽
指紋
網路
專案
(5)
研究成果
(80)
資料集
(1)
類似的個人檔案
(6)
指紋
查看啟用 Chia-Chang Wu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Adjuvant Chemotherapy
11%
Androgen Deficiency
8%
Bladder
28%
Bladder Cancer
16%
Cancer Specific Survival
23%
Cardiovascular Disease
14%
Chronic Kidney Disease
9%
Clear Cell Renal Cell Carcinoma
11%
Cohort Analysis
29%
Disease
12%
Disease Free Survival
23%
Erectile Dysfunction
12%
Hazard Ratio
9%
Hernia
10%
Hernioplasty
8%
Herniorrhaphy
12%
Hydronephrosis
15%
Infection
12%
Inguinal Hernia
18%
Injury
8%
Malignant Neoplasm
13%
Meta-Analysis
11%
Metastatic Carcinoma
9%
Methylation
11%
Neoplasm
19%
Nephroureterectomy
64%
Operation Duration
8%
Overall Survival
32%
Pelvic Tumor
9%
Percutaneous Nephrolithotomy
11%
Postoperative Complication
8%
Prevalence
9%
Proportional Hazards Model
9%
Prostate Cancer
29%
Prostate Cell
11%
Recurrence Free Survival
14%
Recurrent Disease
32%
Signal Transduction
12%
Survival Rate
8%
Symptom
21%
Transitional Cell Carcinoma
100%
Treatment Response
14%
Upper Urinary Tract
19%
Ureter Tumor
10%
Urinary System
24%
Urinary Tract
8%
Urolithiasis
7%
Uropathogenic Escherichia Coli
17%
Urothelial Cancer
23%
Varicocelectomy
7%
Pharmacology, Toxicology and Pharmaceutical Science
8 Hydroxydeoxyguanosine
5%
Alpha Tocopherol
5%
Androgen
12%
Apoptosis Inhibitor
5%
Arginine
10%
Atrial Fibrillation
5%
Biochemical Recurrence
5%
Bladder Cancer
14%
Carcinogenicity
5%
Cardiovascular Disease
6%
Case-Control Study
10%
Castration Resistant Prostate Cancer
11%
Chemotherapy
12%
Chronic Prostatitis
5%
Cigarette Smoking
16%
Cohort Study
5%
Disease
8%
Disease Exacerbation
9%
End Stage Renal Disease
5%
Endometriosis
5%
Enzalutamide
6%
Focal Glomerulosclerosis
5%
Glutathione
5%
Hydronephrosis
5%
Infection
11%
Inflammation
7%
Interleukin 8
11%
Malignant Neoplasm
20%
Mediator Complex
5%
Mouse Model
5%
Neoplasm
19%
Nicotine-Derived Nitrosamine Ketone
5%
Overall Survival
15%
Pain
5%
Pelvis Pain Syndrome
6%
Pembrolizumab
5%
Phimosis
5%
Phosphodiesterase V Inhibitor
5%
Prostate Cancer
29%
Prostate Specific Antigen
8%
Protein P53
5%
Recurrent Disease
21%
Renal Cell Carcinoma
17%
Sulfotransferase 1A1
5%
Toll Like Receptor 4
5%
Transferase
5%
Transitional Cell Carcinoma
70%
Tumor Necrosis Factor
16%
Uropathogenic Escherichia Coli
17%
Vardenafil
5%
Biochemistry, Genetics and Molecular Biology
Anticancer
6%
Cancer Cell
5%
Case-Control Study
10%
Cigarette Smoking
10%
Cohort Study
5%
Coronavirinae
5%
Disease Free Survival
5%
Enzalutamide
6%
Gene Promoter
11%
Genetics
5%
Genotyping
13%
Gleason Score
5%
Helicobacter Pylori
5%
Inhibitor of Apoptosis
5%
Interleukin 6
5%
Interleukin 8
12%
Macrophage
5%
Mediator Complex
5%
Metabolomics
5%
Methylation
5%
Mortality Rate
5%
Overall Survival
9%
Passive Smoking
13%
Pembrolizumab
5%
Promoter Region
5%
Prostate-Specific Antigen
9%
SARS Coronavirus
5%
Shear Stress
5%
Signal Transduction
12%
Smoking
5%
SOX2
5%
SRD5A1
5%
STAT1
8%
STAT3
5%
Survival Rate
5%
Survivin
5%
Testosterone Blood Level
5%
TLR4
5%
Tumor Necrosis Factor
14%
Tumor Necrosis Factor Alpha
11%
Tumor Volume
8%
Upregulation
6%
Uropathogenic Escherichia Coli
17%
Vascular Endothelial Growth Factor
7%
